Document is current
Any future updates will be listed below
-
Authors
Du, Wenjuan
Debski-Antoniak, Oliver https://orcid.org/0000-0001-8239-2738
Drabek, Dubravka https://orcid.org/0000-0002-9781-1701
van Haperen, Rien
van Dortmondt, Melissa
van der Lee, Joline https://orcid.org/0000-0002-4628-9001
Drulyte, Ieva https://orcid.org/0000-0003-1117-7699
van Kuppeveld, Frank J. M. https://orcid.org/0000-0001-5800-749X
Grosveld, Frank https://orcid.org/0000-0002-7051-4715
Hurdiss, Daniel L. https://orcid.org/0000-0003-3834-5808
Bosch, Berend-Jan https://orcid.org/0000-0002-3864-232X
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (101005077)
- License Information
-
More Information
Article History
Received: 8 December 2023
Accepted: 11 June 2024
First Online: 22 June 2024
Competing interests
: D.D., R.H., and F.G. are employees of Harbour Biomed and hold company shares. I.D. is an employee of Thermo Fisher Scientific. The remaining authors declare no competing interests.
